Evaluation of methemoglobin as an autologous intravascular MRI contrast agent

Magnetic Resonance in Medicine

Volumn 35, Issue 5, 1996, Pages 787-789

  Duewell, Stefan ^a,b   Kasserra, Claudia E ^a   Jezzard, Peter ^a   Balaban, Robert S ^a  

^a National Institutes of Health   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

magnetic resonance imaging; methemoglobin; Paramagnetic contrast agent

Indexed keywords

MAGNETIC RESONANCE IMAGING;

CONVERSION AGENTS; INTRAVASCULAR; METHEMOGLOBIN; MRI CONTRAST AGENTS; PARAMAGNETIC CONTRASTS; RABBIT KIDNEY; SIGNAL INTENSITIES; TIME CONSTANTS;

PARAMAGNETISM;

CONTRAST MEDIUM; METHEMOGLOBIN;

ANIMAL EXPERIMENT; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; IMAGE ENHANCEMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 0029935201     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910350521     Document Type: Article

References (13)

1. N. Wilke, M. Jerosch-Herold, A.E. Stillman, K. Kroll, N. Tsedos, H. Merkle, T. Parrish, X. Hu, J. Bassinghte, R. J. Bache, K. Ugurbil, Concepts of myocardial perfusion imaging in magnetic resonance imaging. Magn. Reson. Quart. 10, 249-286 (1994).
2. M. D. Ogan, U. Schmiedl, M. E. Moseley, W. Grodd, H. Paajanen, R. C. Brasch, Albumin labelled with Gd-DPTA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest. Radiol. 22, 665-671 (1987).
3. S. C. Wang, M. G. Wikstrom, D. L. White, J. Klaveness, E. Holtz, P. Rongved, M. E. Moseley, R. C. Brasch, Evaluation of Gd-DPTA-labelled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology 175, 483-488 (1990).
4. I. Bertini, C. Luchinat, "NMR of Paramagnetic Molecules in Biological Systems," Benjamin Cummings, CA, 1986.
5. S. Ogawa, D. W. Tank, R. S. Menon, J. M. Ellerman, S. G. Kim, H. Merkle, K. Ugurbil, Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc. Natl. Acad. Sci. (USA) 89, 5951-5955 (1992).
6. C. Gasparovic, N. A. Matwiyoff, The magnetic properties and water dynamics of the red blood cell: a study by proton NMR lineshape analysis. Magn. Reson. Med. 26, 274-299 (1992).
7. P. A. Janick, D. B. Hackney, R. I. Grossman, T. Asakura, MR imaging of various oxidation states of intracellular and extracellular hemoglobin. AJNR 12, 891-897 (1991).
8. B. A. Scharf, R. F. Fricke, S. I. Baskin, Comparison of methemoglobin formers in protection against the toxic effects of cyanide. Gov. Rep. Ann. Index 18, (1992).
9. N. Kiese, N. Weger, Formation of ferrihaemoglobin with aminophenols in the human for the treatment of cyanide poisoning. Eur. J. Pharmacol. 7, 97-105 (1969).
10. G. D. Fullerton, in "Magnetic Resonance Imaging" (D. D. Stark, W. G. Bradley, (Eds.), pp. 88-108, Mosby, Chicago, 1993.
11. G. McKinnon, Ultrafast interleaved gradient echo planar imaging on a standard scanner. Magn. Reson. Med. 30, 609-616 (1993).
12. R. Klimmek, C. Krettek, L. Szinicz, P. Eyer, N. Weger, Effects and biotransformation of 4-dimethylaminophenol in man and dog. Arch. Toxicol. 53, 275-288 (1983).
13. R. Elbers, P. Eyer, H. Kampffmeyer, S. Soboll, Organ toxicity and metabolic pathway of 4-dimethylaminophenol. Adv. Exp. Med. Biol. 136 Pt A, 419-429 (1981).